Distributed by

ROCHE HONG KONG LTD

Featured products of Roche

ALECENSA

ALECENSA cap 150 mg

alectinib

Packing/Price

224's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01ED03 - alectinib : Belongs to the class of anaplastic lymphoma kinase (ALK) inhibitors. Used in the treatment of cancer.

Avastin Roche

Avastin Roche infusion 100 mg/4 mL

bevacizumab

Packing/Price

(single-use) 1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FG01 - bevacizumab : Belongs to the class of VEGF/VEGFR (Vascular Endothelial Growth Factor / Receptors) inhibitors. Used in the treatment of cancer.

Enspryng

Enspryng soln for inj 120 mg/mL

satralizumab

Packing/Price

1's

MIMS Class

Immunosuppressants

ATC Classification

L04AC19 - satralizumab : Belongs to the class of interleukin inhibitors. Used as immunosuppressants.

Evrysdi

Evrysdi powd for oral soln 0.75 mg/mL

risdiplam

Packing/Price

((strawberry flavour)) 80 mL x 1's

MIMS Class

Other Drugs Acting on Musculo-Skeletal System

ATC Classification

M09AX10 - risdiplam : Belongs to the class of other drugs for disorders of the musculo-skeletal system.

Herceptin SC

Herceptin SC soln for inj 600 mg/5 mL

trastuzumab

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FD01 - trastuzumab : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.

Kadcyla

Kadcyla powd for infusion 100 mg

trastuzumab emtansine

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FD03 - trastuzumab emtansine : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.

Kadcyla powd for infusion 160 mg

trastuzumab emtansine

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FD03 - trastuzumab emtansine : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.

Ocrevus

Ocrevus conc for soln for infusion 30 mg/mL

ocrelizumab

Packing/Price

10 mL x 1's

MIMS Class

Immunosuppressants

ATC Classification

L04AG08 - ocrelizumab : Belongs to the class of monoclonal antibodies. Used as immunosuppressants.

Phesgo

Phesgo soln for inj 1,200/600 mg

pertuzumab, trastuzumab

Packing/Price

15 mL x 1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FY01 - pertuzumab and trastuzumab : Belongs to the class of combinations of monoclonal antibodies and antibody drug conjugates. Used in the treatment of cancer.

Phesgo soln for inj 600/600 mg

pertuzumab, trastuzumab

Packing/Price

10 mL x 1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FY01 - pertuzumab and trastuzumab : Belongs to the class of combinations of monoclonal antibodies and antibody drug conjugates. Used in the treatment of cancer.

Rozlytrek

Rozlytrek hard cap 100 mg

entrectinib

Packing/Price

30's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01EX14 - entrectinib : Belongs to the class of other protein kinase inhibitors. Used in the treatment of cancer.

Rozlytrek hard cap 200 mg

entrectinib

Packing/Price

90's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01EX14 - entrectinib : Belongs to the class of other protein kinase inhibitors. Used in the treatment of cancer.

Tamiflu

Tamiflu powd for oral susp 6 mg/mL

oseltamivir phosphate

Packing/Price

65 mL x 1's

MIMS Class

Antivirals

ATC Classification

J05AH02 - oseltamivir : Belongs to the class of neuraminidase inhibitors. Used in the systemic treatment of viral infections.

Tecentriq

Tecentriq conc for soln for infusion 1,200 mg/20 mL

atezolizumab

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy, Cancer Immunotherapy

ATC Classification

L01FF05 - atezolizumab : Belongs to the class of PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors. Used in the treatment of cancer.

Tecentriq conc for soln for infusion 840 mg/14 mL

atezolizumab

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy, Cancer Immunotherapy

ATC Classification

L01FF05 - atezolizumab : Belongs to the class of PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors. Used in the treatment of cancer.

Vabysmo

Vabysmo soln for intravitreal inj 6 mg/0.05 mL

faricimab

Packing/Price

1's

MIMS Class

Other Eye Preparations

ATC Classification

S01LA09 - faricimab : Belongs to the class antineovasculatisation agents. Used in the management of neovascular macular degeneration.

Xofluza

Xofluza FC tab 20 mg

baloxavir marboxil

Packing/Price

4's2's

MIMS Class

Antivirals

ATC Classification

J05AX25 - baloxavir marboxil : Belongs to the class of other antivirals. Used as a direct acting antiviral in the systemic treatment of viral infections.

Xofluza FC tab 40 mg

baloxavir marboxil

Packing/Price

1's2's

MIMS Class

Antivirals

ATC Classification

J05AX25 - baloxavir marboxil : Belongs to the class of other antivirals. Used as a direct acting antiviral in the systemic treatment of viral infections.

Distributed by Agencia Lei Va Hong

ALECENSA

ALECENSA cap 150 mg

alectinib

Packing/Price

224's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01ED03 - alectinib : Belongs to the class of anaplastic lymphoma kinase (ALK) inhibitors. Used in the treatment of cancer.

Avastin Roche

Avastin Roche infusion 100 mg/4 mL

bevacizumab

Packing/Price

(single-use) 1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FG01 - bevacizumab : Belongs to the class of VEGF/VEGFR (Vascular Endothelial Growth Factor / Receptors) inhibitors. Used in the treatment of cancer.

Tecentriq

Tecentriq conc for soln for infusion 1,200 mg/20 mL

atezolizumab

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy, Cancer Immunotherapy

ATC Classification

L01FF05 - atezolizumab : Belongs to the class of PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors. Used in the treatment of cancer.

Tecentriq conc for soln for infusion 840 mg/14 mL

atezolizumab

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy, Cancer Immunotherapy

ATC Classification

L01FF05 - atezolizumab : Belongs to the class of PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors. Used in the treatment of cancer.

Distributed by DKSH

ALECENSA

ALECENSA cap 150 mg

alectinib

Packing/Price

224's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01ED03 - alectinib : Belongs to the class of anaplastic lymphoma kinase (ALK) inhibitors. Used in the treatment of cancer.

Avastin Roche

Avastin Roche infusion 100 mg/4 mL

bevacizumab

Packing/Price

(single-use) 1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FG01 - bevacizumab : Belongs to the class of VEGF/VEGFR (Vascular Endothelial Growth Factor / Receptors) inhibitors. Used in the treatment of cancer.

Enspryng

Enspryng soln for inj 120 mg/mL

satralizumab

Packing/Price

1's

MIMS Class

Immunosuppressants

ATC Classification

L04AC19 - satralizumab : Belongs to the class of interleukin inhibitors. Used as immunosuppressants.

Evrysdi

Evrysdi powd for oral soln 0.75 mg/mL

risdiplam

Packing/Price

((strawberry flavour)) 80 mL x 1's

MIMS Class

Other Drugs Acting on Musculo-Skeletal System

ATC Classification

M09AX10 - risdiplam : Belongs to the class of other drugs for disorders of the musculo-skeletal system.

Herceptin SC

Herceptin SC soln for inj 600 mg/5 mL

trastuzumab

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FD01 - trastuzumab : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.

Kadcyla

Kadcyla powd for infusion 100 mg

trastuzumab emtansine

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FD03 - trastuzumab emtansine : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.

Kadcyla powd for infusion 160 mg

trastuzumab emtansine

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FD03 - trastuzumab emtansine : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.

Ocrevus

Ocrevus conc for soln for infusion 30 mg/mL

ocrelizumab

Packing/Price

10 mL x 1's

MIMS Class

Immunosuppressants

ATC Classification

L04AG08 - ocrelizumab : Belongs to the class of monoclonal antibodies. Used as immunosuppressants.

Phesgo

Phesgo soln for inj 1,200/600 mg

pertuzumab, trastuzumab

Packing/Price

15 mL x 1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FY01 - pertuzumab and trastuzumab : Belongs to the class of combinations of monoclonal antibodies and antibody drug conjugates. Used in the treatment of cancer.

Phesgo soln for inj 600/600 mg

pertuzumab, trastuzumab

Packing/Price

10 mL x 1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FY01 - pertuzumab and trastuzumab : Belongs to the class of combinations of monoclonal antibodies and antibody drug conjugates. Used in the treatment of cancer.

Rozlytrek

Rozlytrek hard cap 100 mg

entrectinib

Packing/Price

30's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01EX14 - entrectinib : Belongs to the class of other protein kinase inhibitors. Used in the treatment of cancer.

Rozlytrek hard cap 200 mg

entrectinib

Packing/Price

90's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01EX14 - entrectinib : Belongs to the class of other protein kinase inhibitors. Used in the treatment of cancer.

Tamiflu

Tamiflu powd for oral susp 6 mg/mL

oseltamivir phosphate

Packing/Price

65 mL x 1's

MIMS Class

Antivirals

ATC Classification

J05AH02 - oseltamivir : Belongs to the class of neuraminidase inhibitors. Used in the systemic treatment of viral infections.

Tecentriq

Tecentriq conc for soln for infusion 1,200 mg/20 mL

atezolizumab

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy, Cancer Immunotherapy

ATC Classification

L01FF05 - atezolizumab : Belongs to the class of PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors. Used in the treatment of cancer.

Tecentriq conc for soln for infusion 840 mg/14 mL

atezolizumab

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy, Cancer Immunotherapy

ATC Classification

L01FF05 - atezolizumab : Belongs to the class of PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors. Used in the treatment of cancer.

Vabysmo

Vabysmo soln for intravitreal inj 6 mg/0.05 mL

faricimab

Packing/Price

1's

MIMS Class

Other Eye Preparations

ATC Classification

S01LA09 - faricimab : Belongs to the class antineovasculatisation agents. Used in the management of neovascular macular degeneration.

Xofluza

Xofluza FC tab 20 mg

baloxavir marboxil

Packing/Price

4's2's

MIMS Class

Antivirals

ATC Classification

J05AX25 - baloxavir marboxil : Belongs to the class of other antivirals. Used as a direct acting antiviral in the systemic treatment of viral infections.

Xofluza FC tab 40 mg

baloxavir marboxil

Packing/Price

1's2's

MIMS Class

Antivirals

ATC Classification

J05AX25 - baloxavir marboxil : Belongs to the class of other antivirals. Used as a direct acting antiviral in the systemic treatment of viral infections.

Distributed by Firma Chun Cheong

Tamiflu

Tamiflu powd for oral susp 6 mg/mL

oseltamivir phosphate

Packing/Price

65 mL x 1's

MIMS Class

Antivirals

ATC Classification

J05AH02 - oseltamivir : Belongs to the class of neuraminidase inhibitors. Used in the systemic treatment of viral infections.